Baby Bridget, born on June 27th, became the first baby conceived in Ireland using pre-implantation genetic diagnosis (PGD), a technique used…
PatrĂcia Silva, PhD
PatrĂcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĂcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by PatrĂcia Silva, PhD
Vertex Submits FDA Supplemental New Drug Application for Kalydeco in People with R117H CF Mutation
In the wake of recent promising clinical results, Vertex Therapeutics announced the submission of a supplemental New Drug…
Hemolung Respiratory Assist System (RAS) is an innovative Pittsburgh-made, dialysis-like alternative or supplement to mechanical ventilation that is not approved by…
Drug developer Pharmaxis has announced that the company’s medication for cystic fibrosis, Bronchitol, was included in the shortlist for…
In the wake of positive news about new combination therapies involving the Vertex drug…
Half of the adults who suffer from cystic fibrosis (CF) are infected with the aspergillus fungus, according to medical…
Boomer Esiason Foundation Helps Children’s Hospital Raise $2 Million for CF and Pulmonary Programs
lev radin / Shutterstock.com An initiative organized last Saturday to support the Cincinnati Children’s Hospital…
A drug derived from Norwegian seaweed may help increase the life expectancy of people with cystic fibrosis,…
Bernstein Research analyst Geoff Porges advised investors about the probability of failure of the Vertex Pharmaceuticals’ experimental cystic fibrosis…
Clinical-stage biotech company Galapagos, which is based in Belgium, has announced positive results of a Phase II clinical trial for…